Overview Report Highlights: How checkpoint inhibitors are revolutionizing treatment options and expectations for cancer patients An overview of global melanoma market Case studies on Opdivo, Keytruda .....
Overview Report Highlights: An overview of deal activity for top 10 oncology companies in June 2014 Deal details (financial/strategic) What are the most important drivers for deals Deal insi.....
Overview Report Highlights: An overview of Glatopa (regulatory, marketing, clinical details) An overview of global multiple sclerosis market The report analyses the impact of Glatopa launch on industr.....
Overview Report Highlights: Regulations around approval biosimilars in the US An overview of global biosimilar market Case study on the US approval of Zarxio (Biosimilar of Amgen’s Neupogen)
Overview REPORT HIGHLIGHTS · What is the opinion of top 10 oncology companies on high prices? Which are the most recurring words in media? · What are the trends in oncolog.....
Overview India faces formidable challenges in providing suffi cient energy of desired quality in desired forms in a sustainable manner at competitive or affordable prices. Yet, none of this is insurmountable. Given that India has explored only 22% of i.....
Overview This report presents the dynamics of Indian Telecom Industry compiled exhaustively titled “Kinetics of Indian Telecom Industry-2014”.The telecommunications sector plays an increasingly important role in the Indian economy. It contr.....
Overview The report highlights the significant potential for value creation along the different segments of the value chain for technologies, including project planning, manufacturing, installation, grid connection, operation and maintenance and decomm.....
Overview This is an Investor Series report which provides the information on: Wind Turbine Design and Characteristics Permits and Licensing Site Selection Criteria Economics and Financial Mo.....
Overview I am pleased to inform you that iData Insights, which has been in the forefront in providing high quality services in Research and Consultancy domains under its segment “Guide to Investor Series” is coming up with a discursive feas.....
